News

BC Partners Completes Sale of Suddenlink to Altice

21 Dec 2015

Altice N.V. (Euronext: ATC, ATCB) today announced it has completed the acquisition of 70% of the share capital of Suddenlink from existing shareholders BC Partners , CPP Investment Board and Suddenlink management. BC Partners and CPP Investment Board have retained a 30% stake in Suddenlink, as planned.  The closing was achieved on Altice's originally stated timeline, following the receipt of all federal and local regulatory approvals.

BC Partners acquires Cigierre

12 Nov 2015

Milan – 12 November 2015 – Funds advised by BC Partners (“BC Partners”), a leading international private equity firm, have reached an agreement to acquire a majority stake in Cigierre (“the Company”), Italy’s leading restaurant chain, from the founder and CEO Marco Di Giusto, as well as L Capital and Paladin Capital Partners. The transaction is subject to regulatory approvals and is expected to close early in 2016.

BC Partners to acquire Dümmen Orange

16 Oct 2015

Funds advised by BC Partners (“BC Partners”), a leading private equity firm, have reached an agreement to acquire a majority stake in Dümmen Orange (“the Company”), the global leader in the floricultural breeding sector, from H2 Equity Partners and the Dümmen family. The transaction is subject to regulatory approvals and is expected to close in the coming months.

BC Partners acquires Côte Restaurants

14 Jul 2015

Funds advised by BC Partners (“BC Partners”), a leading European private equity firm, have acquired a majority stake in Côte Restaurants Limited (“Côte” or the “Company”), the fast-growing UK restaurant chain. Management will be retaining a significant shareholding. Terms of the transaction are not disclosed. 

BC Partners acquires Pharmathen

03 Jun 2015

Funds advised by BC Partners (“BC Partners”), a leading international private equity firm, have reached an agreement to acquire a majority stake in Pharmathen S.A (“Pharmathen” or “the Company”), a leading European pharmaceutical company. BC Partners will partner with Pharmathen’s founders who will remain as shareholders in the Company. The transaction is subject to regulatory approvals and is expected to close in the coming months.

BC Partners completes sale of 25,000,000 ordinary shares in Com Hem Holding AB (the "Company")

19 Mar 2015

Further to the announcement by BC Partners on 19 March 2015, BC Partners has completed the sale of 25,000,000 ordinary shares (the "Placing Shares") representing 12% of the issued share capital of the Company at a price of  SEK 76 per Placing Share.